Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors

被引：0
|
作者：
Freimark, Bruce [1 ]
Gong, Jian [1 ]
Van Nguyen [1 ]
Yin, Shen [1 ]
Archer, Rich [1 ]
Hutchins, Jeff [1 ]
机构：
[1] Peregrine Pharmaceut, Tustin, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.SABCS14-P5-04-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-04-12
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting of phosphatidylserine by monoclonal antibodies enhances the activity of immune checkpoint inhibitors in breast tumors
    Gong, Jian
    Yin, Shen
    Nguyen, Van
    Hutchins, Jeff
    Freimark, Bruce D.
    CANCER RESEARCH, 2015, 75
  • [2] Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in tumors
    Gong, Jian
    Van Nguyen
    Yin, Shen
    Archer, Rich
    Hutchins, Jeff
    Freimark, Bruce
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Targeting of phosphatidylserine by monoclonal antibodies enhances the activity of immune checkpoint lag3 targeting antibodies in murine breast tumors
    Gray, M. J.
    Gong, J.
    Hutchins, J. T.
    Freimark, B. D.
    CANCER RESEARCH, 2017, 77
  • [4] Targeting of phosphatidylserine by monoclonal antibodies augments the activity of immune checkpoint inhibitor PD-1/PD-L1 therapy in murine breast tumors
    Gray, M.
    Gong, J.
    Nguyen, V.
    Hutchins, J.
    Freimark, B.
    CANCER RESEARCH, 2016, 76
  • [5] Targeting phosphatidylserine-mediated immune suppression enhances the efficacy of immune checkpoint blockade in preclinical tumor models of melanoma and breast
    Hutchins, J.
    Freimark, B.
    Brekken, R.
    Huang, X.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S2 - S3
  • [6] Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors
    Rom Keshet
    Joo Sang Lee
    Lital Adler
    Muhammed Iraqi
    Yarden Ariav
    Lisha Qiu Jin Lim
    Shaul Lerner
    Shiran Rabinovich
    Roni Oren
    Rotem Katzir
    Hila Weiss Tishler
    Noa Stettner
    Omer Goldman
    Hadas Landesman
    Sivan Galai
    Yael Kuperman
    Yuri Kuznetsov
    Alexander Brandis
    Tevi Mehlman
    Sergey Malitsky
    Maxim Itkin
    S. Eleonore Koehler
    Yongmei Zhao
    Keyur Talsania
    Tsai-wei Shen
    Nir Peled
    Igor Ulitsky
    Angel Porgador
    Eytan Ruppin
    Ayelet Erez
    Nature Cancer, 2020, 1 : 894 - 908
  • [7] Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors
    Keshet, Rom
    Lee, Joo Sang
    Adler, Lital
    Iraqi, Muhammed
    Ariav, Yarden
    Lim, Lisha Qiu Jin
    Lerner, Shaul
    Rabinovich, Shiran
    Oren, Roni
    Katzir, Rotem
    Tishler, Hila Weiss
    Stettner, Noa
    Goldman, Omer
    Landesman, Hadas
    Galai, Sivan
    Kuperman, Yael
    Kuznetsov, Yuri
    Brandis, Alexander
    Mehlman, Tevi
    Malitsky, Sergey
    Itkin, Maxim
    Koehler, S. Eleonore
    Zhao, Yongmei
    Talsania, Keyur
    Shen, Tsai-wei
    Peled, Nir
    Ulitsky, Igor
    Porgador, Angel
    Ruppin, Eytan
    Erez, Ayelet
    NATURE CANCER, 2020, 1 (09) : 894 - +
  • [8] Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors
    Assi, Rita
    Kantarjian, Hagop
    Ravandi, Farhad
    Daver, Naval
    CURRENT OPINION IN HEMATOLOGY, 2018, 25 (02) : 136 - 145
  • [9] Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
    Gravbrot, Nicholas
    Gilbert-Gard, Kacy
    Mehta, Paras
    Ghotmi, Yarah
    Banerjee, Madhulika
    Mazis, Christopher
    Sundararajan, Srinath
    ANTIBODIES, 2019, 8 (04)
  • [10] TARGETING OF MONOCLONAL-ANTIBODIES TO TUMORS
    COURTENAYLUCK, NS
    EPENETOS, AA
    CURRENT OPINION IN IMMUNOLOGY, 1990, 2 (06) : 880 - 883
12345